🔎 Trials Near Me

Akèy › Kasinom Selil Transizyonèl (Urotelyal) › Oregon › Portland

Etid klinik pou Kasinom Selil Transizyonèl (Urotelyal) nan Portland, OR

7 etid pou Kasinom Selil Transizyonèl (Urotelyal) ap chèche patisipan nan sit nan ak bò kote Portland (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

Ap rekriteFaz 1
  • Exelixis Clinical Site #51, Portland
Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT05176483

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

Ap rekriteFaz 2
  • Providence Portland Medical Center, Portland
  • Providence Saint Vincent Medical Center, Portland
  • Oregon Health and Science University, Portland
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT03866382

Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer

Ap rekriteFaz 1/2
  • Northwest Cancer Specialists, P.C., Portland
  • Northwest Cancer Specialists, P.C., Portland
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07421700

A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract

Ap rekriteFaz 3
  • Providence Portland Medical Center, Portland
  • Providence St. Vincent Medical Center, Portland
  • Kaiser Permanente Interstate Medical Office Central, Portland
  • ak 1 plis
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07218380

Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors

Ap rekriteFaz 1
  • Providence Portland Medical Center, Portland
Laj 18 ak plis · Tout sèks · Mizajou Sep 10, 2026 · NCT06293898

A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors

Ap rekriteFaz 1/2
  • Providence Cancer Center Oncology and Hematology Care- Eastside, Portland
Laj 18 ak plis · Tout sèks · Mizajou Aug 17, 2026 · NCT04895709

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Ap rekriteEtid obsèvasyon
  • Massive Bio SYNERGY-AI site, Portland
Tout laj · Tout sèks · Mizajou Oct 28, 2025 · NCT03452774

Etid Kasinom Selil Transizyonèl (Urotelyal) nan lòt vil

Lòt etid nan Portland

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.